UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM ESTCompany ParticipantsBritt Vitalone - Executive VP ...

McKesson Corporation MCK reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $9.86, which beat the Zacks ...

Discover key insights from McKesson’s Q2 2026 earnings call, including record growth, raised guidance, and strategic investments.

Healthcare distributor and services company McKesson (NYSE:MCK) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 10.1% year on year to $103.2 billion. Its non-GAAP profit of ...

This quarter, analysts are expecting McKesson’s revenue to grow 11.2% year on year to $104.1 billion, slowing from the 21.3% ...

McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.

Inventory management is now considered a prime candidate for automation as manufacturers target opportunities to reduce costs, accelerate product delivery and make the most out of experienced talent.

Undeniably, as discussed during the conference’s e-trading panel, automation and electronification can offer huge advantages to traders, such as speeding up workflows and adding efficiencies, however ...

Workflow automation is rapidly becoming the backbone of modern business — not just a productivity boost, but a complete rethink of how work moves across teams and tools. It’s no longer about faster ...

Startup Alvys Inc., which has built an artificial intelligence-based transportation management system for orchestrating freight operations, has boosted its war chest with a $40 million Series B round ...

Sept 23 (Reuters) - McKesson (MCK.N), opens new tab on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth ...

McKesson MCK0.87%increase; green up pointing triangle updated its targets for fiscal 2026 and beyond as the diversified healthcare services company continues to advance its growth strategy. The ...